136 related articles for article (PubMed ID: 25002294)
21. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
Connick E; Kane MA; White IE; Ryder J; Campbell TB
Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
[TBL] [Abstract][Full Text] [Related]
22. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
[TBL] [Abstract][Full Text] [Related]
23. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
26. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.
Campbell TB; Borok M; Gwanzura L; MaWhinney S; White IE; Ndemera B; Gudza I; Fitzpatrick L; Schooley RT
AIDS; 2000 Sep; 14(14):2109-16. PubMed ID: 11061651
[TBL] [Abstract][Full Text] [Related]
27. Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence.
Ngalamika O; Mukasine MC; Kawimbe M; Vally F
PLoS One; 2021; 16(7):e0254177. PubMed ID: 34214127
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
Gill J; Bourboulia D; Wilkinson J; Hayes P; Cope A; Marcelin AG; Calvez V; Gotch F; Boshoff C; Gazzard B
J Acquir Immune Defic Syndr; 2002 Dec; 31(4):384-90. PubMed ID: 12447008
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
[TBL] [Abstract][Full Text] [Related]
30. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
31. Specific pattern of circulating endothelial adhesion molecules in HIV-associated Kaposi's sarcoma.
Becker K; Heins M; Südhoff T; Reinauer H; Häussinger D
Int Arch Allergy Immunol; 1997 Aug; 113(4):512-5. PubMed ID: 9250599
[TBL] [Abstract][Full Text] [Related]
32. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.
Mosam A; Hurkchand HP; Cassol E; Page T; Cassol S; Bodasing U; Aboobaker J; Dawood H; Friedland GH; Coovadia HM
Int J STD AIDS; 2008 Jun; 19(6):400-5. PubMed ID: 18595878
[TBL] [Abstract][Full Text] [Related]
34. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
35. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
Nguyen HQ; Magaret AS; Kitahata MM; Van Rompaey SE; Wald A; Casper C
AIDS; 2008 May; 22(8):937-45. PubMed ID: 18453853
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus-related microvasculopathy and Kaposi's sarcoma: a case-control study.
Baumann S; Geier SA; Thoma-Gerber E; Noehl MA; Klauss V; Goebel FD
Ger J Ophthalmol; 1995 Jul; 4(4):239-45. PubMed ID: 7492937
[TBL] [Abstract][Full Text] [Related]
37. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
Whitby D; Howard MR; Tenant-Flowers M; Brink NS; Copas A; Boshoff C; Hatzioannou T; Suggett FE; Aldam DM; Denton AS
Lancet; 1995 Sep; 346(8978):799-802. PubMed ID: 7674745
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
39. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]